Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-02-13 11:31 am Sale | 13G | BISON CAP ACQUISITION CORP BCAC | Polar Asset Management Partners Inc. | 235,936 0.51% | -557,379 (-70.26%) | View |
| 2020-02-12 4:44 pm Unchanged | 13G | XYNOMIC PHARMACEUTICALS HLDGS XYN | BOOTHBAY FUND MANAGEMENT LLC | 0 0% | 0 (Unchanged) | View |
| 2019-06-06 12:35 pm Purchase | 13D | XYNOMIC PHARMACEUTICALS HLDGS XYN | Bison Capital Holding Co Ltd | 1,588,393 3.43% | 1,588,393 (New Position) | View |
| 2019-05-30 3:09 pm Purchase | 13D | XYNOMIC PHARMACEUTICALS HLDGS XYN | Qian Tingzhi | 7,517,707 16.24% | 7,517,707 (New Position) | View |
| 2019-05-30 11:52 am Purchase | 13D | XYNOMIC PHARMACEUTICALS HLDGS XYN | Wu Wentao Jason | 5,612,618 12.13% | 5,612,618 (New Position) | View |
| 2019-05-29 1:48 pm Purchase | 13D | XYNOMIC PHARMACEUTICALS HLDGS XYN | Xu Yinglin Mark | 21,009,055 45.4% | 21,009,055 (New Position) | View |